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SUM M ARY
Human peripheral blood monocytes from normal, healthy donors express the leucocyte function- 
associated antigen (LFA)-l, CR3 and pi 50,95. These heterodimeric antigens are members of a 
glycoprotein family sharing a common beta subunit but endowed with distinct alpha chains. They 
have been shown to play an important role in cell-cell interactions. In the present study we have 
investigated the role of these molecules in the interaction of monocytes with endothelial cells and 
melanoma (tumour) cells. Heterotypic cell-cell interactions were studied in single cell conjugate 
assays and by adhesion of monocytes to monolayers of cells. The results demonstrate that 
monoclonal antibodies directed against LFA-1 alpha, CR3 alpha, pi 50,95 alpha and the common 
beta chain strongly reduce the number of conjugates (71, 50, 60 and 89% inhibition, respectively), 
formed between monocytes and melanoma or endothelial cells in a single cell assay. In contrast, 
adhesion of monocytes to monolayers of the same cells seems only to depend on pi 50,95, since only 
antibodies directed to the alpha chain of this moleculc and to the common beta chain inhibited 
adhesion. Interestingly, the number of conjugates formed with melanoma cells in single cell assays 
was at least twice the number of conjugates formed between monocytes and endothelial cells, whereas
no differences were observed in the adhesion of monocytes to monolayers o f  these ceils. However, the
i _
basis for this phenomenon is not yet clear. These results indicate that not only LFA-1 but also CR3 
and p i 50,95 can mediate adhesion to target cells in suspension, but that monocyte adhesion to 
monolayers is caused by a different mechanism in which the p i 50,95 molecule seems to play a 
prominent role.
IN TR O D U C TIO N
One of the molecules involved in the non-specific adhesion of 
target cells to lymphocytic cytotoxic effector cells (Springer el 
al., 1982; Krensky et a i , 1984; Spits et al., 1986) is the leucocyte 
function-associated antigen (LFA)-l. The LFA-1 molecule is 
crucial for lytic interaction between cytotoxic T cells (CTL) or 
natural killer cells and their respective targets (Krensky et a i , 
1984; Schmidt et ai, 1985). It is widely distributed and expressed 
by T and B lymphocytes, null cells, monocytes and granulo­
cytes, and is composed of two non-covalently associated 
molecules, an alpha chain of 170,000 MW and a beta chain of
95,000 MW. LFA-1 is structurally related to the antigens CR3
Abbreviations: ACD, acid citrate dextrose; BSA, bovine serum 
albumin; CTL, cytotoxic T  lymphocyte; DM EM, Dulbecco's modifica­
tion of  Eagles minimal essential medium; FCS, fetal calf serum; FÏTC, 
lluoresccin isothiocyanate; G A M , goat anti-mouse; LFA-I, leucocyte 
function-associated antigen-J; PBS, phosphate-buffered saline.
Correspondence: Dr A. A. te Velde, Division of  Immunology, The 
Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, 
The Netherlands.
and p i 50,95 ccll surface molecules, since they share the same 
beta chain (95,000 MW, CD 18) but have distinct alpha chains 
(170,000, 165,000 and 150,000 MW, respectively for LFA-1, 
CR3 and pi 50,95 (CD 11)) (Sanchez-Mad rid et al., 1983; Keizer 
etaL, 1985). Both CR3 and pi 50,95 are expressed by monocytes 
and granulocytes but arc generally absent on T and B lympho­
cytes (Todd et al., 1982; Lainer et al., 1985).
The role of LFA-1 in CTL interaction is well documented 
but much less is known about the function of the LFA-1 family 
molecules in monocyte cell-cell interactions. This prompted us 
to study the role of the LFA-1 family molecules in the 
interaction of monocytes to two cell types that are involved in 
important adhesion phenomena: melanoma cells (monocytes as 
potential cytotoxic effector cells) and endothelial cells (physio­
logical blood cell adhesion). Recent findings indicate that the 
LFA-1 family molecules mediate adhesion and migration of 
human monocytes (G. D. Keizer et a l submitted for publica­
tion). In the present study wc demonstrate that on human 
monocytes not only LFA-1 but also CR3 and p i 50,95 play an 
important role in the adhesion to melanoma cells and endo­
thelial cells.
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M A T E R IA L S A N D  M E T H O D S
Monoc)'te isolation
Highly purified peripheral blood monocytes were isolated from 
blood of normal human donors as described previously (Figdor 
etui,  1982, 1984). Briefly, the mononuclear cells of a buffy coat, 
prepared from 500 ml blood containing acid citrate dextrose 
(ACD), obtained from the Central Laboratory of the Nether­
lands Red Cross Blood Transfusion Service (Amsterdam, The 
Netherlands) were isolated by density centrifugation with a 
blood component separator and subsequently fractionated to 
monocytes and lymphocytes by centrifugal élutriation. The 
monocyte preparation was over 95% pure {non-specific esterase 
and May Grunwald Giemsa staining) and the viability of the 
cells was always more than 95% as judged by means of trypan 
blue exclusion.
Cultured cells
Melanoma cell lines established in our laboratory as described 
previously (De Vries, Rumke & Bernheim, 1972) were grown in 
Dulbecco’s modification of Eagles minimal essential medium 
(DMEM) supplemented with streptomycin (50 /¿g/rnl), penicil­
lin (100 lU/ml), NaH-CO? (3*7 g/1), glutamine (2 mM) and 10% 
fetal calf serum (PCS; Gibco, Paisley, Renfrewshire, U.K.). 
Human endothelial cells, isolated from human umbilical cord 
veins, were obtained from Dr J. H. Reinders from the Central 
Laboratory of the Netherlands Red Cross Blood Transfusion 
Service (Amsterdam, The Netherlands). These cells were cul­
tured in RPMI-1640 medium (Flow Laboratories, Irvine, 
Ayrshire, U.K.), supplemented with 20% human serum, penicil­
lin, streptomycin» fungizone and 2 mM glutamine,
Monoclonal an tiho dies
The following monoclonal antibodies were used. SPV-L7 
recognizes the alpha chain of LFA-1. It precipitates a 170,000/
95.000 MW complex and was obtained as described previously 
(Spits et ctl., 1983). Bear-1 was found to be similar to anti-CR3 
and OKM-1 (Todd et aL, 1982; Keizer e f  a l , 1985) and 
precipitated a 165,000/95,000 MW complex that is found to be 
associated with C3bi receptor function (Beller, Springer & 
Schreiber, 1982). S-HC1 3, kindly provided by Dr R. Schwart- 
ing (Schwarting, Stein & Wang, 1985) precipitated a 150,000/
95.000 molecule. CLB54 is directed against the beta chain of 
LFA-1, CR3 and pi 50,95 (Miedema et al, 1984). Other 
monoclonal antibodies used were Bear-2, which reacts with a 
monocyte-specific differentiation antigen with a MW of 55,000 
and is similar to Mo2 (Todd et at., 1982) (data not shown). This 
antibody was used as a control for positive antibody binding. 
CEM III 2 .1.1 specific for keyhole limpet haemocyanin was used 
as a control antibody for negative antibody binding. In 
addition, two melanoma-specific antibodies were used, AMF-6 
and AMF-7 (De Vries et a l, 1986). These antibodies were 
selected for their capacity to inhibit the reaction of cytotoxic T- 
lymphocyte clones that preferentially lysed human melanoma
cells. AMF-6 (225,000/>450,000 MW) reacts with a high MW 
melanoma-associated proteoglycan. AMF-7 (150,000/90,000) 
detects a melanoma-associated surface membrane antigen that 
is involved in the adhesion and spreading of melanoma cells. 
This antigen was termed 'melanoma-associated cellular ad­
hesion molecule-1* (MACAM-1) (De Vries et a l , 1986). The 
isotype of the test and control monoclonal antibodies are of the
IgGl subclass, except S-HC1 3 antibody, which is of the IgG2b 
isotype. The reaction pattern of a control antibody of the IgG2b 
isotype did not differ from that of the IgGl control antibodies 
(results not shown).
Membrane immunofluorescence
Adherent cells were detached with EDTA (5 mM), resuspended 
in DMEM supplemented with 10% FCS and washed with PBS 
containing BSA (0-2%) and azide (0-02%). Ceils (1-3 xlO5) 
were incubated for 30 min at 0° with the various monoclonal 
antibodies (1:1000 ascites dilution). After this incubation 
period the cells were washed twice with PBS (-1- BSA -f azide) 
and incubated with FITC-labelled GAM F(ab)3 (1:30 diluted, 
Nordic, Tilburg, The Netherlands) for 30 min at 0°. Finally, 0-5 
ml PBS ( +  BSA4- azide) was added and the relative fluorescence 
intensity of the cells was analysed with a FACS (FACS IV, 
Becton-Dickinson, Mountain View, CA).
Monocyte conjugate assay in suspension 
A modification of the method of Bonavida, Bradley & Grimm 
(1983) was used to determine conjugate formation on a single 
cell level. Freshly isolated human peripheral blood monoytes 
were used as effector cells in binding to melanoma cell lines, 
human endothelial cells, lymphocytes and erythrocytes. After 
washing twice with PBS the monocytes were labelled with 
carboxy fluorescein diacetate (CFDA) to distinguish them from 
the target cells under the fluorescence microscope. Monocytes 
and target cells were incubated for 30 min with or without 
antibodies in a 1:1 ratio in medium with or without 10% human 
serum at 30°; subsequently the cell suspension was centrifuged 
for 5 min at 200# to establish conjugate formation. The pellet 
was resuspended in 1 % molten agarose (1:5 ratio of type I and 
VII agarose, Sigma, St Louis, MO) and plated onto slides. After 
fixation in 0*04% formaldehyde in PBS the percentage conju­
gates was determined. The percentage of conjugates was 
determined by:
number of bound monocytes to target 
total number of monocytes X 100.
Adhesion of monocytes to monolayers
The capacity of monocytes to adhere to various substrates was 
determined by means of an ELISA (Keizer, Figdor & De Vries, 
1986). Monocytes were labelled with anti-monocyte antibodies 
coupled to peroxidase by incubation at 4° for 45 min. It was 
demonstrated that these anti-monocyte antibodies did not aifect 
the adherent proportion of the monocytes. Subsequently the 
cells were washed twice in PBS and resuspended in serum-free 
medium, Linolea (Yssel et a l , 1984). Cells (5 x 104) were then 
incubated with or without antibodies for 30 min at 37°, 5% C 0 2 
and 100% humidity in a 96-well tissue culture plate (Costar 
3596, Cambridge, U.K.) that contained a monolayer of target 
cells. After the incubation period the non-adhering monocytes 
were removed by washing with PBS. The number of attached 
peroxidase-labelled cells was determined by adding substrate 
and photospectrometric determination of the staining in a one- 
step ELISA. The staining correlated directly with the number of 
adherent cells as was determined by a standard calibration curve 
or by counting the number of non-adherent cells (not shown). 
The values obtained with cells incubated in the absence of 
antibodies was set at 100%.
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RESULTS
Expression of LFA-1, CR3 and p i50,95 and melanoma- 
associated antigens by monocytes, melanoma and endothelial cells
In order to show that LFA-1, CR3 and p i50,95 are only 
expressed on monocytes and not on melanoma and endothelial 
cells we incubated human monocytes, melanoma cells (BK-mel) 
and endothelial cells with various antibodies. The results in 
Table 1 show that LFA-1, CR3 and p i50,95 are present on the 
monocytes, and that these molecules are not expressed by these 
melanoma cells and endothelial cells. In accordance with 
previous data (De Vries et aL , 1986) the antibodies AMF-6 and 
AMF-7 recognized melanoma-associated antigens, which are 
not expressed on monocytes and endothelial cells, except AMF- 
7 which showed cross-reactivity with the cultured endothelial 
cells.
Requirements for conjugate formation in suspension
In order to determine the conditions necessary for conjugate 
formation between monocytes and other cells we investigated 
the temperature dependence and the requirement for calcium 
and/or magnesium ions in monocyte conjugate formation. In 
Table 2 it is demonstrated that only minimal binding occurs at 
temperatures of  0' compared to 30", indicating that the 
conjugate formation between monocytes and melanoma cells or 
endothelial cells is temperature dependent. Furthermore, conju­
gate formation was found to be Mg2 f dependent, whereas Ca24 
was not required.
Time-course of conjugate formation in suspension
When monocytes are incubated with melanoma or endothelial 
cells striking differences in the degree of binding can be
Table 1. Expression of LFA-1, CR3 and p i 50,95 and melanoma-associated antigens





Neg. control KLM (0)1*
SPV-L7 LFA-1 (a chain) I3 (95)
Bear-1 Mol (oc chain) 2 1 (94)
S-HC1 3 p i 50,95 (a chain) 9(90)
CLB54 LFA-1, Mol, 24 (94)
p i 50,95 [ßchain)
Bear-2 Mo2 8(87)
AMF-6 BM W  antigen I (I)
AMF-7 MACAM-1 1 (1)
BK melanoma cells Endothelial cells
1 (0) 1 (0)
1 (2) 1 (5)
1 (4) I (6)
1 (3) 1 (2)
I (4) 1 (6)
1 (3) 1 (4)
5 (84) 1 (8)
8 (93) 3(49)
* Cells were labelled with monoclonal antibody and G A M  F(ab)2 F IT C  directly 
after separation (monocytes) or after culture for 1 week (endothelial cells) or  
prolonged culture (melanoma cells).
t  Data are expressed as mean relative fluorescence index and mean percentage 
positive cells (in parentheses). Similar results were obtained in two other experiments.
Table 2, Requirements for conjugate formation of monocytes and melanoma or endothelial
cells
% conjugates between monocytes and:
BK melanoma cells Endothelial cells 
Temperature of Human s e r u m , ------------------------------- --------  -------------------------
conjugate formation Mg2 + o r C a 21 added Donor 1 D onor  2 D o n o r  1 Donor
ii
cOm
Human serum 41 25 27 13
0( Human serum 5 4 3 2
30° --------- 9 3 4 2
30" Mg2+ and Ca2f 39 20 22 13
30° Mg2'1' 41 20 25 14
30° Ca2+ 10 6 6 4
Conjugate formation was performed as described in the Materials and M ethods at 30’ and 
0°. Mg2 h and Ca2 1 were added in a concentration of 0-0025% w/v and  0*005% w/v, 
respectively. Data shown are the percentage fluorescent monocytes in conjugates. Three- 
hundred monocytes were counted to determine percentage conjugate formation.
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Table 3. Inhibition o f  conjugate formation between monocytes
and melanoma or endothelial cells*
Antibodies added
% inhibition of conjugate
form ation! between 
monocytes and:
M elanom a cells Endothelial cells
None 0 0
Neg. control (anti-KLH) 10+11 2 +  2
SPV-L7 71 ±  14 64 ± 2
Bear-1 5 0 + 1 6 52 ± 3
S-HC1 3 60 + 1 1 57 + 4
CLB54 86 ± 1 0 89 ±  3
Bear-2 8 + 1 1 7 ± 4
AM F-6 - 1 1 + 2 0 7 +  2
AM F-7 - 2 6  +  26 9 +  5
* Conjugate formation was performed as described in the 
Materials and Methods. Antibodies were added in a concen­
tration o f  5-10 (iglml,
t  D a ta  shown are the mean percentage inhibition ± S E  
calculated by the formula:
I - conjugate formation +  antibodies
conjugate formation control ( — antibodies)
x 100.
Three ■'hundred monocytes were counted  to determine percent­
age conjugate formation. Five different inhibition experiments 
were carried out. The number o f  conjugates formed between 
monocytes and melanoma cells ranged from 25 to 41% with 
different monocyte preparations. With endothelial cells the 
maximum number o f  conjugates was 16%.
observed. As shown in Tables 2 and 3 the number of conjugates 
formed between monocytes and melanoma cells was signifi­
cantly higher than that between monocytes and endothelial 
cells. In order to investigate whether optimal conjugate forma-
Figure 1. Time-course of binding o f  human monocytes to melanoma 
cells (BK-mel) (■) and endothelial cells (a ) in suspension. Assay was 
performed as described in the Materials and Methods. Data of one 
representative experiment.
tion between monocytes and melanoma cells or endothelial cells 
required different incubation times, a time-course of conjuga te 
formation in suspension was performed. Figure 1 shows that 
cell-cell adhesion reaches equilibrium within 30 in in at 30 , 
irrespective of the cell type to which the monocyte is bound.
Role of LFA-1, CR3 and p i50,95 in conjugate formation in 
suspension
In order to determine which antigens of the LFA family mediate 
conjugate formation, experiments were carried out in which the 
capacity of various monoclonal antibodies to inhibit conjugate 
formation was studied. Antibodies that recognize LFA-1, CR3 
and p i50,95 inhibited monocyte-melanoma cell and monocyte- 
endothelial cell conjugate formation, while control antibodies 
did not affect this interaction (Table 3). Conjugate formation is 
almost completely blocked by antibodies that recognize the 
common beta chain of LFA-U CR3 and pi 50,95. Furthermore, 
it is demonstrated that antibodies recognizing melanoma- 
associated surface antigens did not inhibit conjugate formation 
between monocytes and melanoma cells. In several experiments 
an enhanced binding of monocytes to melanoma cells was 
observed when the anti-melanoma antibodies were present
Table 4. Inhibition o f  conjugate formation o f  monocytes to melanoma or endothelial
cell monolayers*
% inhibition o f  number of monocytes that
adhere to a monolayerf
Antibodies added Melanoma cells Endothelial cells
N one 0 0
Neg. control (anti-KLH) I ± 2 1±1
SPV-L7 2 +  2 1 + 2
Bea r-1 7 ± 4 7 +  4
S-H C l 3 30 ± 4 30 ± 6
CLB54 28 +  5 29 +  6
Bear-2 1 +1 2 + 1
A M F-6 2 +  1 3 ± 1
A M F -7 3 +  1 3 + 2
* Conjugate formation was performed as described in the Materials and Methods. 
Antibodies were added in a concentration of 5-10 /ig/ml.
t  Data shown are the mean percentage inhibition +  SE calculated by the same 
formula as described in Table 3. Five different inhibition experiments were carried out.
Differential function o f  L F A -1 molecules 265
during conjugate formation. This phenomenon is most prob­
ably caused by binding of the monocyte via its Fc gamma 
reccptor to the antibody-coated melanoma cells, since mono­
cytes of 70% of all donors have a rcceptor for mouse IgG 1 (Tax 
et al., 1984).
Conjugate formation between monocytes and target cells grown in 
monolayer
In order to quantify the proportion of monoytes that adhere to a 
monolayer of cells, an adhesion assay was used in which, prior 
to adhesion, the monocytes were labelled with an antibody 
conjugated to peroxidase. Such labelling does not affect the 
adhesive properties of the cells (Keizer et a l 1986). The number 
of monocytes that binds to a plastic surface is almost 100%, 
whereas approximately 70-80% of the monocytes adhere to 
monolayers of melanoma or endothelial cells. In contrast to 
binding of monocytes and these cells in suspension, binding of 
monocytes to monolayers of melanoma and endothelial cells 
does not depend on the type of target cells used. No differences 
were observed between the number of monocytes that bind to a 
monolayer of melanoma cells compared to the number of  
monocytes that adhere to an endothelial cell monolayer. 
Inhibition studies performed with anti-LFA-1 family antibodies 
demonstrate that only p i 50,95, but not LFA-I or CR3, is 
involved in the adhesion of monocytes to a monolayer of target 
cells (Table 4). Monoclonal antibodies that recognize the 
common beta chain of LFA-1, CR3 and pi 50,95 also markedly 
reduce the number of monocytes that adhere to a target cell 
monolayer.
Anti-melanoma antibodies AMF-6 and AMF-7 had no 
elfect on the number of monocytes that adhere to a monolayer 
of melanoma cells.
In conclusion, these data indicate that antibodies against the 
alpha chains of LFA-1 and CR3 do not contribute to the 
adhesion of monocytes to a monolayer of cells, whereas the 
same antibodies effectively inhibit conjugate formation in a 
single cell assay. Apparently, different interaction mechanisms 
are involved in the formation of conjugates of monocytes with 
single cells and with monolayers of cells.
D ISC U SSIO N
LFA-1, CR3 and pi 50,95 expressed on monocytes are involved 
in the formation of conjugates between monocytes and single 
melanoma or endothelial cells. In contrast, adhesion of mono­
cytes to monolayers of cells seems only to be mediated by the 
alpha chain of pi 50,95, whereas LFA-1 and CR3 play no 
significant role. Furthermore, the results presented here demon­
strate for the first time that different members of this family of  
structurally related antigens contribute to the binding o f  
monocytes to melanoma or endothelial cells in two different 
assays.
Conjugate formation is shown to be a temperature-sensitive 
and Mg2 +-dependent process, which is in agreement with recent 
findings of Pawlowski et al. (1985) who studied monocyte- 
endothelial cell interactions. These findings with monocytes arc 
in line with those obtained with T cells, since Spits el al. (1986) 
and others (Springer et al., 1982) described that binding of CTL 
to specific targets also was dependent on both temperature and 
Mg21 concentration.
LFA-1 is known to be involved in the adhesion strengthen­
ing between effector and target cells (Springer et a l 1982; 
Krensky et al., 1984; Spits et al., 1986). It is most likely that 
LFA-1 expressed on monocytes has the same function in 
conjugate formation between monocytes and target cells in 
suspension. These results correspond with the recent findings of 
Strassmann et al. (1986) who describe participation of LFA-1 in 
the interaction between murine activated macrophages and 
neoplastic cells. Our results show that not only LFA-1, but also 
CR3, mediates conjugate formation between monocytes and 
target cells. The latter finding is in line with previous studies that 
already indicated that CR3 has lectin-like properties and 
promotes adherence between phagocytic cells and certain 
surfaces (Ross, Cain & Lachmann, 1985; Arnaout et a l 1983). 
From these data it can be concluded that CR3, which is mainly 
expressed on monocytes and granulocytes, seems to be respon­
sible for adhesion strengthening on phagocytic cells, similar to 
LFA-1. Interestingly, LFA-1 and CR3 do not participate in the 
adhesion of monocytes to melanoma/endothelial cells when 
these cells arc growing in monolayers. Under these conditions, 
pi 50,95 is the only antigen involved in this interaction. These 
data suggest that the structures to which LFA-1 and CR3 can 
bind are absent or less abundant on the available surface. This 
notion is supported by the finding that cells growing in a 
monolayer show a reorganization of cellular structures when 
they adhere to a substrate. Molecules required for adhesion 
move to the interface substrate/cell surface (Chen & Singer, 
1982). Our data are in accordance with the results reported by 
Harlan et al (1985) and others (Wallis et al., 1985) who suggest 
that a pi 50,95-like antigen is responsible for adherence of 
neutrophils to plastic surfaces and monolayers of cells. 
Recently, Anderson et a l  (1986) described that CR3 mediates 
adherence of granulocytes to a serum-coated surface. Since we 
do not use the same antibodies directed to CR3, it is possible 
that our antibody recognizes a different epitope that is not 
involved in monocyte adhesion to a plastic or cell surface, but 
plays a role in monocyte cell-cell interaction. In addition, it is 
evident that molecules other than LFA-1 family glycoproteins 
are involved in this process since the addition of anti-pl 50,95 
antibodies to monocytes that adhere to a substrate results in a 
blocking percentage of  only 30%. Furthermore, these observa­
tions indicate that LFA-1 and CR3 might function as receptors 
that recognize counterstructures on target cells in suspension, 
whereas only p i 50,95 appears to be involved in adhesion of 
monocytes to monolayers of cells.
Up until now it has been unclear whether the common beta 
chain of LFA-1, CR3 and pi 50,95 itself contributes to cell-cell 
interactions, A known function of  the beta chain is that it is 
required for the surface expression of the alpha-beta hetcro- 
dimer complexes of these molecules (Sanchez-Mad rid et a l , 
1983; Springer et a l , 1984).
An interesting finding is the significantly higher number of 
monocytes that bind in suspension to melanoma (tumour) cells 
in comparison to endothelial cells (Fig. 1). A possible explana­
tion could be that monocytes have receptors recognizing 
determinants more strongly expressed on malignant cells. This 
preferential adhesion is supported by recent data indicating that 
the number of conjugates formed between monocytcs and 
melanoma cells is higher than the number of conjugates formed 
between monocytes and normal human fibroblasts (te Velde et 
a l , 1986). The regulation of the mechanism underlying a
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differential binding of  monocytes to malignant versus non- 
malignant cells in suspension deserves further investigation.
The binding of monocytes to melanoma cells and endothe­
lial cells does not result in lysis in a 3-hr single cell cytotoxic 
assay (results not shown). This is in line with data of others 
(Koren & Herberman, 1985), who show that monocytes isolated 
by centrifugal élutriation do not spontaneously lyse target cells, 
not even in 24-hr assays. Monocytes probably need to be 
activated for tumour cell killing, which is currently under 
investigation.
Taken together, these data indicate that the LFA-1 family 
molecules are involved in the binding of  monocytes to tumour 
cells and to endothelial cells suggesting that these molecules are 
involved in monoyte tumour cytotoxicity and that they may be 
associated with extravasation of monocytes through vessel 
walls.
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